\BOOKMARK [0][-]{part.1}{I Ter\340pia Cel\267lular}{}% 1
\BOOKMARK [1][-]{section.1}{Embrionic Stem Cells}{part.1}% 2
\BOOKMARK [2][-]{subsection.1.1}{Stem Cells}{section.1}% 3
\BOOKMARK [2][-]{subsection.1.2}{Blastocist pre-implantacional}{section.1}% 4
\BOOKMARK [2][-]{subsection.1.3}{Obtenci\363 de c\350l\267lules mare embrion\340ries}{section.1}% 5
\BOOKMARK [2][-]{subsection.1.4}{Marcadors}{section.1}% 6
\BOOKMARK [2][-]{subsection.1.5}{Manteniment de la pluripot\350ncia}{section.1}% 7
\BOOKMARK [1][-]{section.2}{Adult Stem Cells}{part.1}% 8
\BOOKMARK [2][-]{subsection.2.1}{C\350l\267lules mare hematopoi\350tiques}{section.2}% 9
\BOOKMARK [2][-]{subsection.2.2}{C\350l\267lules mare mesenquimals}{section.2}% 10
\BOOKMARK [1][-]{section.3}{Ter\340pia cel\267lular per malalties coron\340ries}{part.1}% 11
\BOOKMARK [2][-]{subsection.3.1}{Infart de miocardi}{section.3}% 12
\BOOKMARK [2][-]{subsection.3.2}{Estrat\350gies de ter\340pia}{section.3}% 13
\BOOKMARK [1][-]{section.4}{induced Pluripotent Stem Cells}{part.1}% 14
\BOOKMARK [2][-]{subsection.4.1}{C\350l\267lules som\340tiques vs ESC}{section.4}% 15
\BOOKMARK [2][-]{subsection.4.2}{Reprogramaci\363 cel\267lular}{section.4}% 16
\BOOKMARK [2][-]{subsection.4.3}{Models de reprogramaci\363}{section.4}% 17
\BOOKMARK [2][-]{subsection.4.4}{M\350todes}{section.4}% 18
\BOOKMARK [2][-]{subsection.4.5}{Caracteritzaci\363 de la pluripot\350ncia}{section.4}% 19
\BOOKMARK [1][-]{section.5}{C\350l\267lules mare neurals}{part.1}% 20
\BOOKMARK [2][-]{subsection.5.1}{Proliferaci\363 al SNC}{section.5}% 21
\BOOKMARK [1][-]{section.6}{Estudis de llinatge cel\267lular}{part.1}% 22
\BOOKMARK [2][-]{subsection.6.1}{Proliferaci\363 cel\267lular}{section.6}% 23
\BOOKMARK [2][-]{subsection.6.2}{Seguiment del llinatge cel\267lular}{section.6}% 24
\BOOKMARK [0][-]{part.2}{II Ter\340pia G\350nica}{}% 25
\BOOKMARK [1][-]{section.7}{Introducci\363 a la ter\340pia g\350nica}{part.2}% 26
\BOOKMARK [2][-]{subsection.7.1}{Concepte de ter\340pia g\350nica}{section.7}% 27
\BOOKMARK [2][-]{subsection.7.2}{Estrat\350gies de ter\340pia g\350nica}{section.7}% 28
\BOOKMARK [2][-]{subsection.7.3}{Aproximacions de la ter\340pia g\350nica}{section.7}% 29
\BOOKMARK [2][-]{subsection.7.4}{Vectors de ter\340pia g\350nica}{section.7}% 30
\BOOKMARK [1][-]{section.8}{Gens de selecci\363 i gens reporters}{part.2}% 31
\BOOKMARK [2][-]{subsection.8.1}{Gens reporters}{section.8}% 32
\BOOKMARK [2][-]{subsection.8.2}{Gens de selecci\363}{section.8}% 33
\BOOKMARK [2][-]{subsection.8.3}{\300cids nucleics usats en ter\340pia g\350nica}{section.8}% 34
\BOOKMARK [1][-]{section.9}{Estrat\350gies de ter\340pia g\350nica}{part.2}% 35
\BOOKMARK [2][-]{subsection.9.1}{Increment d'expressi\363/addici\363 g\350nica}{section.9}% 36
\BOOKMARK [2][-]{subsection.9.2}{Eliminaci\363 de c\350l\267lules: gens su\357cida i activaci\363 del sistema immunitari}{section.9}% 37
\BOOKMARK [2][-]{subsection.9.3}{Inhibici\363 dirigida de l'expressi\363 g\350nica}{section.9}% 38
\BOOKMARK [2][-]{subsection.9.4}{Correcci\363 de la mutaci\363}{section.9}% 39
\BOOKMARK [1][-]{section.10}{Models cel\267lulars i animals}{part.2}% 40
\BOOKMARK [1][-]{section.11}{Gene delivery}{part.2}% 41
\BOOKMARK [2][-]{subsection.11.1}{M\350todes de transfecci\363 cel\267lular}{section.11}% 42
\BOOKMARK [2][-]{subsection.11.2}{Vectors virals}{section.11}% 43
\BOOKMARK [2][-]{subsection.11.3}{Entrega del gen in vivo}{section.11}% 44
\BOOKMARK [1][-]{section.12}{Vectors no virals}{part.2}% 45
\BOOKMARK [2][-]{subsection.12.1}{Captaci\363 cel\267lular de DNA nu}{section.12}% 46
\BOOKMARK [2][-]{subsection.12.2}{M\350todes qu\355mics}{section.12}% 47
\BOOKMARK [2][-]{subsection.12.3}{M\350todes f\355sics}{section.12}% 48
\BOOKMARK [1][-]{section.13}{Barreres cel\267lulars}{part.2}% 49
\BOOKMARK [2][-]{subsection.13.1}{Entrega sist\350mica i barreres extracel\267lulars}{section.13}% 50
\BOOKMARK [2][-]{subsection.13.2}{Interacci\363 cel\267lular}{section.13}% 51
\BOOKMARK [2][-]{subsection.13.3}{Captaci\363}{section.13}% 52
\BOOKMARK [2][-]{subsection.13.4}{Sortida de l'endosoma i estabilitat al citoplasma}{section.13}% 53
\BOOKMARK [2][-]{subsection.13.5}{Transport nuclear}{section.13}% 54
\BOOKMARK [1][-]{section.14}{Vectors virals}{part.2}% 55
\BOOKMARK [2][-]{subsection.14.1}{Introducci\363}{section.14}% 56
\BOOKMARK [2][-]{subsection.14.2}{Adenovirus}{section.14}% 57
\BOOKMARK [2][-]{subsection.14.3}{Virus adenoassociats}{section.14}% 58
\BOOKMARK [2][-]{subsection.14.4}{Retrovirus}{section.14}% 59
\BOOKMARK [2][-]{subsection.14.5}{Exemples}{section.14}% 60
\BOOKMARK [0][-]{section*.1}{Refer\350ncies}{}% 61
